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Fig. 2. Effect of drugs on (A) 5-HT2B, GSK-3b, P-GSK-3b and b-catenin; (B) P-Akt, Akt, P-eNOS and eNOS; (C) Bax, NF-jBp65 and IKK-b and (D) Bcl2, MnSOD and Nox4 protein
expressions. The data is presented as mean ± S.D. of three independent experiments and one way ANOVA followed by Bonferroni post hoc test was used to compare the groups.
Value of P < 0.05 was considered signiﬁcant. Data are expressed as a ratio of normal control value (set to 100). ⁄P < 0.001 versus NC, dP < 0.01 versus NC and P < 0.001 versus ISO.
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